Related Experiment Video
Updated: Aug 1, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
A descriptive observational study of B12 testing during pregnancy and infancy in New Zealand and suggested guidance
Asher Henry1, Natasha Heather2, Campbell Kyle3
1Paediatric Fellow, Whakatāne Hospital, Bay of Plenty, New Zealand.
Insights
Vitamin B12 deficiency in infants and mothers is inadequately detected and treated in Auckland. A risk-based screening approach is recommended to improve diagnosis and management of this critical nutrient deficiency.
Area of Science:
- Maternal and Child Health
- Nutritional Science
- Public Health
Background:
- Severe Vitamin B12 deficiency poses significant risks to infant health.
- Antenatal and infant Vitamin B12 status is crucial for development.
- Understanding regional detection and treatment rates is essential for improving care.
Purpose of the Study:
- To assess the recent detection and treatment rates of antenatal and infant Vitamin B12 deficiency in the Auckland-Northland region.
- To identify gaps in current testing and treatment guidelines.
- To provide recommendations for improved screening and management.
Main Methods:
- Analysis of regional laboratory data on serum B12 levels.
- Identification and pairing of B12 deficient infants and pregnant women.
- Review of electronic health records for treatment patterns.
Main Results:
- Low infant testing incidence (5/1,000 infants/year); 6% of tested infants had B12 deficiency.
- 16% of pregnant women tested had antenatal B12 deficiency (2% high-risk).
- Suboptimal treatment rates for both deficient infants and mothers; low testing in high-risk pregnancies.
Conclusions:
- Current Auckland-Northland guidelines inadequately address B12 deficiency in pregnancy and infancy.
- A risk-based screening approach is recommended for early detection of infant deficiency.
- Recommendations for antenatal/postnatal B12 testing, treatment, and nutritional advice are proposed.
Aims:
Severe B12 deficiency is harmful to infants. This study describes the recent detection and treatment rates of antenatal and infant B12 deficiency in the Auckland-Northland region.
Method:
Regional laboratory data on serum B12 levels were analysed. B12 deficient infants and pregnant women were identified and paired with their corresponding mother or infant, followed by a review of electronic health records.
Results:
Testing incidence was low in infants (5 per 1,000 infants per year). Among 529 infants tested over 5 years, 6% exhibited B12 deficiency (<148pmol/L). Antenatal B12 deficiency was found in 16% of 6,365 pregnant women tested over 1 year, with high-risk deficiency (<100pmol/L) found in 2%. Both infants and mothers with B12 deficiency had suboptimal rates of adequate treatment. Among infants of high-risk B12 deficient pregnancies, only 1% had serum B12 tested despite being at high risk of infant B12 deficiency.
Conclusion:
Current guidelines and testing practices in Auckland-Northland inadequately detect and treat B12 deficiency in pregnancy and infancy. A risk-based screening approach is best suited to detect infants at risk of severe deficiency. Antenatal and postnatal recommendations for B12 testing and treatment of mothers and infants are made, along with nutritional advice in pregnancy and infancy.
More Related Videos
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota